Literature DB >> 7751694

Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users.

R D Semba1, W T Caiaffa, N M Graham, S Cohn, D Vlahov.   

Abstract

A nested case-control study of vitamin A deficiency and wasting as risk factors for mortality from AIDS and infections was done within a large prospective cohort of human immunodeficiency virus (HIV)-infected injection drug users (IDUs). Fifty adult subjects who died from AIDS and infections were matched with 235 controls who survived. Plasma vitamin A, weight, and body mass index were measured. Mean length of follow-up was 2.4 +/- 1.1 years. Vitamin A deficiency occurred in 50% and wasting occurred in 38% of patients in the last visit before death. CD4 cells count < 200/microL, wasting, and vitamin A deficiency were associated with mortality. There was a higher risk of death in HIV-infected subjects with vitamin A deficiency (odds ratio [OR], 4.6; 95% confidence interval [CI], 1.8-11.3) and wasting (OR, 8.8; 95% CI, 2.7-28.2). Vitamin A deficiency and wasting are common during HIV infection and are independent predictors of mortality in HIV-infected IDUs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751694     DOI: 10.1093/infdis/171.5.1196

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Community-based DOT-HAART accompaniment in an urban resource-poor setting.

Authors:  Maribel Muñoz; Karen Finnegan; Jhon Zeladita; Adolfo Caldas; Eduardo Sanchez; Miriam Callacna; Christian Rojas; Jorge Arevalo; Jose Luis Sebastian; Cesar Bonilla; Jaime Bayona; Sonya Shin
Journal:  AIDS Behav       Date:  2009-04-16

Review 2.  Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Authors:  Louise Kuhn; Ingrid Peterson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat.

Authors:  Harry L June; Andrew Rong Song Tzeng Yang; Joseph L Bryant; Odell Jones; Walter Royal
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

4.  Vitamin A levels and human immunodeficiency virus load in injection drug users.

Authors:  R D Semba; H Farzadegan; D Vlahov
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 5.  Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes.

Authors:  Eduardo Villamor; Wafaie W Fawzi
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells.

Authors:  Walter Royal; Michelle V Leander; Reid Bissonnette
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

7.  Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A-Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection.

Authors:  Yuejin Liang; Panpan Yi; Xiaofang Wang; Biao Zhang; Zuliang Jie; Lynn Soong; Jiaren Sun
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

8.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.

Authors:  Timothy M Hanley; Heather L B Kiefer; Aletta C Schnitzler; Jennifer E Marcello; Gregory A Viglianti
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  Vitamin A for non-measles pneumonia in children.

Authors:  J Ni; J Wei; T Wu
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.